News

Royalty Pharma plc (NASDAQ:RPRX) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Call Transcript May 8, 2025 Royalty Pharma plc beats earnings expectations. Reported EPS is $1.06, ...
Cutaneous Lupus Erythematosus Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In April 2025, Pfizer organized a study is to learn about the effects, safety and how PF-06823859 is processed in adults with ...